Cite
Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with apigenin in rat plasma by UPLC–MS/MS.
MLA
Alzoman, Nourah Z., et al. “Comparative Pharmacokinetic Profiles of Selected Irreversible Tyrosine Kinase Inhibitors, Neratinib and Pelitinib, with Apigenin in Rat Plasma by UPLC–MS/MS.” Journal of Pharmaceutical & Biomedical Analysis, vol. 137, Apr. 2017, pp. 258–67. EBSCOhost, https://doi.org/10.1016/j.jpba.2017.01.039.
APA
Alzoman, N. Z., Shehata, S. M., Abahussain, A. O., & Maher, H. M. (2017). Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with apigenin in rat plasma by UPLC–MS/MS. Journal of Pharmaceutical & Biomedical Analysis, 137, 258–267. https://doi.org/10.1016/j.jpba.2017.01.039
Chicago
Alzoman, Nourah Z., Shereen M. Shehata, Ashwag O. Abahussain, and Hadir M. Maher. 2017. “Comparative Pharmacokinetic Profiles of Selected Irreversible Tyrosine Kinase Inhibitors, Neratinib and Pelitinib, with Apigenin in Rat Plasma by UPLC–MS/MS.” Journal of Pharmaceutical & Biomedical Analysis 137 (April): 258–67. doi:10.1016/j.jpba.2017.01.039.